291 related articles for article (PubMed ID: 33148520)
1. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.
Machek SB; Cardaci TD; Wilburn DT; Willoughby DS
Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520
[TBL] [Abstract][Full Text] [Related]
2. Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.
Wu C; Kovac JR
Curr Urol Rep; 2016 Oct; 17(10):72. PubMed ID: 27535042
[TBL] [Abstract][Full Text] [Related]
3. Selective androgen receptor modulators in preclinical and clinical development.
Narayanan R; Mohler ML; Bohl CE; Miller DD; Dalton JT
Nucl Recept Signal; 2008; 6():e010. PubMed ID: 19079612
[TBL] [Abstract][Full Text] [Related]
4. Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials.
Fonseca GWPD; Dworatzek E; Ebner N; Von Haehling S
Expert Opin Investig Drugs; 2020 Aug; 29(8):881-891. PubMed ID: 32476495
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the growing public interest in selective androgen receptor modulators.
Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
[TBL] [Abstract][Full Text] [Related]
6. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
[TBL] [Abstract][Full Text] [Related]
7. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
Yarrow JF; McCoy SC; Borst SE
Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Choi SM; Lee BM
Expert Opin Drug Saf; 2015; 14(11):1773-85. PubMed ID: 26401842
[TBL] [Abstract][Full Text] [Related]
9. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery.
Segal S; Narayanan R; Dalton JT
Expert Opin Investig Drugs; 2006 Apr; 15(4):377-87. PubMed ID: 16548787
[TBL] [Abstract][Full Text] [Related]
11. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport.
Bohlin KP; Pohanka A; Andersson A; Villén T; Ekström L
Drug Test Anal; 2023 Nov; ():. PubMed ID: 37986708
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects and potential benefits among selective androgen receptor modulators users: a cross-sectional survey.
Efimenko IV; Valancy D; Dubin JM; Ramasamy R
Int J Impot Res; 2022 Dec; 34(8):757-761. PubMed ID: 34471228
[TBL] [Abstract][Full Text] [Related]
13. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
14. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
[TBL] [Abstract][Full Text] [Related]
15. Investigation of stability of selective androgen receptor modulators in urine.
Ventura E; Gadaj A; Buckley T; Mooney MH
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2020 Aug; 37(8):1253-1263. PubMed ID: 32401172
[TBL] [Abstract][Full Text] [Related]
16. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
17. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
18. Selective androgen receptor modulators: the future of androgen therapy?
Christiansen AR; Lipshultz LI; Hotaling JM; Pastuszak AW
Transl Androl Urol; 2020 Mar; 9(Suppl 2):S135-S148. PubMed ID: 32257854
[TBL] [Abstract][Full Text] [Related]
19. Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis.
Patt M; Beck KR; Di Marco T; Jäger MC; González-Ruiz V; Boccard J; Rudaz S; Hartmann RW; Salah M; van Koppen CJ; Grill M; Odermatt A
Biochem Pharmacol; 2020 Feb; 172():113781. PubMed ID: 31884045
[TBL] [Abstract][Full Text] [Related]
20. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
